Security key
29446K106
Equillium, Inc. - Common Stock, par value $0.0001 per share (EQ)
CUSIP: 29446K106
Q3 2025 13F Holders as of 30 Sep 2025
- Type / Class
- Equity / Common Stock, par value $0.0001 per share
- Shares outstanding
- 66,704,586
- Total 13F shares
- 29,653,795
- Share change
- +20,944,744
- Total reported value
- $42,404,231
- Price per share
- $1.43
- Number of holders
- 40
- Value change
- +$30,732,112
- Number of buys
- 28
- Number of sells
- 14
Report period
Q3 2025
Institutions
40
Top holders
10
EQ full security history
Newer quarter: Q4 2025
Previous quarter: Q2 2025
Equillium, Inc. SEC filings
Equillium, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 29446K106
Recent filing periods:
Top shareholders of EQ - Equillium, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Adage Capital Management, L.P. |
13D/G
|
— |
10%
|
6,012,624
|
$8,596,850 | $0 | 30 Sep 2025 | |
| Woodline Partners LP |
13D/G
|
— |
5.9%
|
3,508,771
|
$5,016,841 | $0 | 30 Sep 2025 | |
| Decheng Capital LLC |
13F
|
Company |
6.7%
|
4,447,308
|
$1,401,792 | — | 30 Jun 2025 | |
| TAKEDA PHARMACEUTICAL CO LTD |
13F
|
Company |
2.7%
|
1,824,977
|
$575,233 | — | 30 Jun 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
1.2%
|
824,091
|
$259,588 | — | 30 Jun 2025 | |
| Cota Capital Management, LLC |
13F
|
Company |
0.84%
|
562,278
|
$177,230 | — | 30 Jun 2025 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.41%
|
274,100
|
$86,396 | — | 30 Jun 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.29%
|
196,091
|
$61,819 | — | 30 Jun 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.2%
|
130,705
|
$41,198 | — | 30 Jun 2025 | |
| UBS Group AG |
13F
|
Company |
0.13%
|
83,550
|
$26,319 | — | 30 Jun 2025 | |
| STATE STREET CORP |
13F
|
Company |
0.09%
|
59,720
|
$18,824 | — | 30 Jun 2025 | |
| AlphaCore Capital LLC |
13F
|
Company |
0.08%
|
52,345
|
$16,499 | — | 30 Jun 2025 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
0.06%
|
39,475
|
$12,000 | — | 30 Jun 2025 | |
| PRUDENTIAL FINANCIAL INC |
13F
|
Company |
0.06%
|
39,200
|
$12,356 | — | 30 Jun 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.05%
|
35,019
|
$11,038 | — | 30 Jun 2025 | |
| COMMONWEALTH EQUITY SERVICES, LLC |
13F
|
Company |
0.04%
|
25,000
|
$8,000 | — | 30 Jun 2025 | |
| Baader Bank Aktiengesellschaft |
13F
|
Company |
0.04%
|
23,711
|
$4,618 | — | 30 Jun 2025 | |
| Ground Swell Capital, LLC |
13F
|
Company |
0.02%
|
16,550
|
$5,217 | — | 30 Jun 2025 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.02%
|
15,097
|
$4,759 | — | 30 Jun 2025 | |
| Apollon Wealth Management, LLC |
13F
|
Company |
0.02%
|
13,875
|
$4,373 | — | 30 Jun 2025 | |
| TRITONPOINT WEALTH, LLC |
13F
|
Company |
0.02%
|
13,500
|
$4,255 | — | 30 Jun 2025 | |
| Virtu Financial LLC |
13F
|
Company |
0.02%
|
10,188
|
$3,000 | — | 30 Jun 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.01%
|
7,530
|
$2,373 | — | 30 Jun 2025 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.01%
|
6,514
|
$2,053 | — | 30 Jun 2025 | |
| SIMPLEX TRADING, LLC |
13F
|
Company |
0.01%
|
5,075
|
$1,000 | — | 30 Jun 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0%
|
1,108
|
$349 | — | 30 Jun 2025 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0%
|
1,000
|
$315 | — | 30 Jun 2025 | |
| SBI Securities Co., Ltd. |
13F
|
Company |
0%
|
865
|
$273 | — | 30 Jun 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
179
|
$57 | — | 30 Jun 2025 | |
| Jason A. Keyes |
3/4/5
|
Chief Financial Officer |
—
class O/S missing
|
126,633
|
$82,311 | — | 14 Feb 2025 | |
| Joel Rothman |
3/4/5
|
Chief Development Officer |
—
mixed-class rows
|
233,150
mixed-class rows
|
$33,727 | — | 02 Jan 2024 | |
| Bala S. Manian |
3/4/5
|
Director |
—
mixed-class rows
|
40,000
mixed-class rows
|
— | — | 21 May 2025 | |
| Barbara Troupin |
3/4/5
|
Director |
—
mixed-class rows
|
40,000
mixed-class rows
|
— | — | 21 May 2025 | |
| Charles Douglas McDermott |
3/4/5
|
Director |
—
mixed-class rows
|
40,000
mixed-class rows
|
— | — | 21 May 2025 | |
| Mark Pruzanski |
3/4/5
|
Director |
—
mixed-class rows
|
40,000
mixed-class rows
|
— | — | 21 May 2025 | |
| Martha J. Demski |
3/4/5
|
Director |
—
mixed-class rows
|
40,000
mixed-class rows
|
— | — | 21 May 2025 | |
| Peter Colabuono |
3/4/5
|
Director |
—
class O/S missing
|
20,000
|
— | — | 21 May 2025 | |
| Ph.D. Yu Xu |
3/4/5
|
Director |
—
class O/S missing
|
20,000
|
— | — | 22 May 2024 |
Institutional Holders of Equillium, Inc. - Common Stock, par value $0.0001 per share (EQ) as of Q3 2025
As of 30 Sep 2025,
Equillium, Inc. - Common Stock, par value $0.0001 per share (EQ) was held by
40 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
29,653,795 shares.
The largest 10 holders included
ADAR1 Capital Management, LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., Decheng Capital LLC, Woodline Partners LP, Balyasny Asset Management L.P., STEMPOINT CAPITAL LP, TAKEDA PHARMACEUTICAL CO LTD, VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, and CANTOR FITZGERALD, L. P..
This page lists
40
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2025 vs Q2 2025 Across Filers
Q2 2025 holders
27
Q3 2025 holders
40
Holder diff
13
| Investor | Q2 2025 Shares | Q3 2025 Shares | Share Diff | Share Chg % | Q2 2025 Value $ | Q3 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.